There are distinct global differences in the consumption trends of benzodiazepines and Z-drugs across 67 countries from 2008 to 2018.
Distinct differences in consumption and trends of BZDs and Z-drugs were found across different countries and regions. Further exploration is needed to understand the association and safety of the use of BZDs and Z-drugs in patients with comorbidities.
Ma et al. (2023) studied this question.